MONDAY, July 3, 2023 (HealthDay News) — The trendy weight-loss drug Ozempic could be dangerous for a patient undergoing anesthesia for an operation, according to a new warning from the American Society of Anesthesiologists. Semaglutide (Ozempic, Wegovy) and other drugs of their class known as GLP-1 receptor agonists cause digestionContinue Reading
THURSDAY, June 29, 2023 (HealthDay News) — Pairing exercise with a 10% weight loss can make a major health improvement in people living with obesity and prediabetes, a new study says. Building in regular exercise more than doubled sensitivity to insulin compared to just weight loss alone. This has theContinue Reading
WEDNESDAY, June 28, 2023 (HealthDay News) — Having a couple of drinks a day won’t protect you from obesity or diabetes, a new study suggests. Everybody knows that heavy drinking isn’t good for your health, but whether moderate alcohol consumption is protective or harmful is still open for debate, researchersContinue Reading
TUESDAY, June 27, 2023 (HealthDay News) — Gastric bypass surgery is a potential long-term cure for type 2 diabetes, especially if the procedure is performed before the disease progresses, a new study argues. Among a large group of obese people with type 2 diabetes, about half achieved remission for anContinue Reading
MONDAY, June 26, 2023 (HealthDay News) — After drugmaker Novo Nordisk tweaked its diabetes drug Ozempic into Wegovy — a formulation expressly designed to help users shed pounds — sales of both drugs skyrocketed. Other pharmaceutical giants took notice, and over the past weekend the results of multiple clinical trialsContinue Reading
FRIDAY, June 23, 2023 (HealthDay News) — Diabetes is skyrocketing, with more than 500 million people of all ages living with the disease today and the number of cases worldwide projected to hit 1.3 billion in the next 30 years. “The rapid rate at which diabetes is growing is notContinue Reading
WEDNESDAY, June 21, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Tuesday approved two drugs that have been used in adults with type 2 diabetes for years for use in children aged 10 and up. The approvals of Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) provideContinue Reading
WEDNESDAY, June 21, 2023 (HealthDay News) – The maker of three popular drugs that treat weight loss and diabetes said Tuesday that it has begun legal proceedings against businesses that are selling compounded versions of its products that are not approved by the U.S. Food and Drug Administration. In aContinue Reading
MONDAY, June 19, 2023 (HealthDay news) — Fatty liver disease is increasing rapidly among Americans, outpacing obesity rates across many racial groups and affecting the liver health of millions, a new study reports. Overall, metabolic dysfunction-associated fatty liver disease (MAFLD) in Americans increased 131% during the past three decades, risingContinue Reading
MONDAY, June 19, 2023 (HealthDay News) — Nearly 10 million Americans are at risk for blindness from diabetic retinopathy, a new study finds. In 2021, an estimated 9.6 million people in the United States — 26% of those with diabetes — had the eye illness and nearly 2 million hadContinue Reading